SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-119532
Filing Date
2023-11-17
Accepted
2023-11-17 16:27:06
Documents
12
Period of Report
2023-11-17
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2330139d2_8k.htm   iXBRL 8-K 25665
  Complete submission text file 0001104659-23-119532.txt   200710

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ganx-20231117.xsd EX-101.SCH 3039
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20231117_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20231117_pre.xml EX-101.PRE 22375
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2330139d2_8k_htm.xml XML 3406
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 231419153
SIC: 2834 Pharmaceutical Preparations